Abstract: In a fuel cell including an electrolyte membrane and a pair of electrodes disposed on both sides of the electrolyte membrane, at least one of the electrodes has an electrically conductive nanocolumn that is oriented with an inclination of 60° or less with respect to a planar direction of the electrolyte membrane, a catalyst supported on the electrically conductive nanocolumn, and an electrolyte resin coating the electrically conductive nanocolumn.

Abstract: An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof. In the general formula (I), R1 and R2 represent hydrogen atoms, and the like; R3 represents a hydrogen atom, and the like; X, Y, and Z represent nitrogen atoms, and the like; A represents a phenylene group, and the like; n represents 1 or 2, and the like; and V and W represent oxygen atoms, and the like.

Abstract: An engine speed control system for a work vehicle is disclosed. Storage means (56) stores a predetermined engine speed. A manually operated input device (37, 38) issues an instruction to retrieve the engine speed from the storage means (56). Engine speed control means (50) executes a constant speed control, whereby the engine speed stored in the storage means (56) is set as a target speed on the basis of a first input operation made using the input device (37, 38). The engine speed control means (50) further executes a stored speed change control for allowing the setting of the engine speed stored in the storage means (56) to be changed based on a second, different input operation performed using the input device (37, 38).

Abstract: An engine speed control system for a work vehicle comprises a pedal sensor (32) for detecting an operative position of an accelerator pedal (31); a foot accelerator controller for carrying out foot accelerator control in which the engine speed that corresponds to an output of the pedal sensor (32) is used as a target rotational speed; and upper limit setting device (35) for setting the upper limit of the engine speed. The upper limit rotation control in which the upper limit rotational speed is used as the target rotational speed is carried out when the target engine speed is greater than the upper limit rotational speed set by the upper limit setting device (35).

Abstract: S/N ratios of two radiological images with parallax are made equal. An angle between one of two radiographing directions and a direction perpendicular to a detection plane of a radiation detector is set to be larger than an angle between the other radiographing direction and the direction perpendicular to the detection plane of the radiation detector, and the amount of radiation is controlled such that the amount of radiation reaching the radiation detector from the one radiographing direction is equal to the amount of radiation reaching the radiation detector from the other radiographing direction.

Abstract: A compound represented by the general formula (1): -Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof.

Abstract: A three-dimensional image display apparatus includes an image combiner which combines a grid-like right-eye image and a grid-like left-eye image, which are substantially identical to each other, into a grid-like combined image, and a position adjusting mechanism which adjusts a position of the image combiner with respect to an observer to adjust a blur in the grid-like combined image due to a positional deviation between the grid-like right-eye image and the grid-like left-eye image.

Abstract: An engine controller (76) includes a first mode control module (81) for performing a first mode control in which a fuel injection amount in an engine (1) is obtained based on a first torque-engine rotational speed characteristic, and a second mode control module (82) for performing a second mode control in which the fuel injection amount is obtained based on a second torque-engine rotational speed characteristic. The first mode control module (81) has a first engine load estimation part (81a) for estimating an engine load based on a difference in rotational speed between a non-load engine rotational speed and an actual engine rotational speed, and the second mode control module (82) has a second engine load estimation part (82a) for estimating an engine load based on the fuel injection amount.

Abstract: The invention relates a compound represented by the formula (1): Q1-Q2-C(?O)—N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 represent H or the like; Q1 represents an aromatic ring, heterocyclic ring or the like; Q2 represents a single bond, aromatic ring, heterocyclic ring or the like; Q3 represents a group or the like, Q4 represents an aromatic ring, heterocyclic ring or the like; and T1 represents —CO— or —SO2—, and a medicine which comprises the compound and is useful for thrombosis and embolism.

Abstract: The engine speed control system for a work vehicle has a foot accelerator controller for carrying out foot accelerator control based on a pedal sensor, a hand accelerator controller for carrying out hand accelerator control based on a lever sensor, a manually operated input device, storage means for storing a predetermined engine speed, and a constant rotation controller for carrying out constant rotation control in which the engine speed stored in the storage means is used as the target rotational speed on the basis of an input to the input device. The constant rotation control is carried out when the input device has been operated in the case that the engine speed that corresponds to the output of the lever sensor is greater than an idling speed, and the constant rotation control is terminated when the input device is operated in the case that the engine speed that corresponds to the output of the lever sensor is equal to or less than the idling speed.

Abstract: The present invention relates to diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for treating various diseases based on thromboembolism.

Abstract: A method for treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing is provided.

Abstract: A compound represented by the general formula (1): -Q1-Q2-T0-N(R1)-Q3-(R2)T1Q4 ??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof.

Abstract: In a fuel cell including an electrolyte membrane and a pair of electrodes disposed on both sides of the electrolyte membrane, at least one of the electrodes has an electrically conductive nanocolumn that is oriented with an inclination of 60° or less with respect to a planar direction of the electrolyte membrane, a catalyst supported on the electrically conductive nanocolumn, and an electrolyte resin coating the electrically conductive nanocolumn.

Abstract: The present invention includes an AuGeNi alloy layer (13) provided on an n-type GaAs layer; and a laminate provided on the AuGeNi alloy layer (13), the laminate being composed of a bonding metal layer (15, 17) and a barrier metal layer (16, 18) provided on the bonding metal layer (15, 17). The present invention includes two or more of the laminates. With this configuration, in a GaAs-based contact layer, particularly in an n-type electrode, the surface diffusion of Ga of the semiconductor and Ni of the AuGeNi alloy, which is needed to form an ohmic contact in the n-type electrode, can be suppressed, and a low-resistance ohmic electrode structure and a semiconductor element having the ohmic electrode structure can be provided.

Abstract: A semiconductor laser device includes a first semiconductor laser element and a second semiconductor laser element. The first semiconductor laser element has a first end face window structure that is a region including first impurities formed near an end face, and the second semiconductor laser element has a second end face window structure that is a region including second impurities formed near an end face. The distance from a lower end of a first active layer to a lower end of the first end face window structure is shorter than the distance from a lower end of a second active layer to a lower end of the second end face window structure.

Abstract: The engine speed control system for a work vehicle has a foot accelerator controller for carrying out foot accelerator control based on a pedal sensor, a hand accelerator controller for carrying out hand accelerator control based on a lever sensor, a manually operated input device, storage means for storing a predetermined engine speed, and a constant rotation controller for carrying out constant rotation control in which the engine speed stored in the storage means is used as the target rotational speed on the basis of an input to the input device. The constant rotation control is carried out when the input device has been operated in the case that the engine speed that corresponds to the output of the lever sensor is greater than an idling speed, and the constant rotation control is terminated when the input device is operated in the case that the engine speed that corresponds to the output of the lever sensor is equal to or less than the idling speed.

Abstract: An engine speed control system for a work vehicle comprises a pedal sensor (32) for detecting an operative position of an accelerator pedal (31); a foot accelerator controller for carrying out foot accelerator control in which the engine speed that corresponds to an output of the pedal sensor (32) is used as a target rotational speed; and upper limit setting means (35) for setting the upper limit of the engine speed. The upper limit rotation control in which the upper limit rotational speed is used as the target rotational speed is carried out when the target engine speed is greater than the upper limit rotational speed set by the upper limit setting means (35).

Abstract: An engine speed control system for a work vehicle is disclosed. Storage means (56) stores a predetermined engine speed. A manually operated input device (37, 38) issues an instruction to retrieve the engine speed from the storage means (56). Engine speed control means (50) executes a constant speed control, whereby the engine speed stored in the storage means (56) is set as a target speed on the basis of a first input operation made using the input device (37, 38). The engine speed control means (50) further executes a stored speed change control for allowing the setting of the engine speed stored in the storage means (56) to be changed based on a second, different input operation performed using the input device (37, 38).

Abstract: Drug compositions containing a substituted diamine compound represented by formula (1): Q1-Q2-r-N(R1)-Q3-N(R2)??(1) wherein Q3 represents the following group wherein Q5 represents an alkylene group having 4 carbon atoms, R3 represents a hydrogen atom, and R4 represents a 3-6 membered heterocyclic group which may be substituted; are useful for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.